UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 174 filers reported holding UNIQURE NV in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $512,651 | -46.6% | 76,401 | -8.8% | 0.00% | 0.0% |
| Q2 2023 | $960,394 | -27.2% | 83,804 | +27.9% | 0.00% | 0.0% |
| Q1 2023 | $1,319,270 | -3.9% | 65,505 | +8.2% | 0.00% | 0.0% |
| Q4 2022 | $1,372,101 | +50.6% | 60,525 | +24.6% | 0.00% | 0.0% |
| Q3 2022 | $911,000 | +65.3% | 48,590 | +64.3% | 0.00% | 0.0% |
| Q2 2022 | $551,000 | +14.8% | 29,566 | +11.5% | 0.00% | – |
| Q1 2022 | $480,000 | -8.7% | 26,516 | +4.8% | 0.00% | – |
| Q4 2021 | $526,000 | -50.3% | 25,313 | -23.5% | 0.00% | -100.0% |
| Q3 2021 | $1,058,000 | -90.2% | 33,089 | -90.6% | 0.00% | -83.3% |
| Q2 2021 | $10,803,000 | +256.1% | 350,719 | +289.3% | 0.01% | +200.0% |
| Q1 2021 | $3,034,000 | +35.6% | 90,099 | +45.5% | 0.00% | +100.0% |
| Q4 2020 | $2,237,000 | +79.2% | 61,913 | +82.6% | 0.00% | 0.0% |
| Q3 2020 | $1,248,000 | -19.9% | 33,913 | -1.9% | 0.00% | 0.0% |
| Q2 2020 | $1,558,000 | +1.4% | 34,559 | +6.7% | 0.00% | 0.0% |
| Q1 2020 | $1,537,000 | +16.2% | 32,388 | +75.4% | 0.00% | 0.0% |
| Q4 2019 | $1,323,000 | -55.9% | 18,464 | -75.8% | 0.00% | -66.7% |
| Q3 2019 | $2,999,000 | +44.5% | 76,168 | +186.8% | 0.00% | +50.0% |
| Q2 2019 | $2,076,000 | +81.9% | 26,559 | +38.7% | 0.00% | +100.0% |
| Q1 2019 | $1,141,000 | +131.4% | 19,142 | +11.8% | 0.00% | 0.0% |
| Q4 2018 | $493,000 | -52.0% | 17,126 | -39.4% | 0.00% | 0.0% |
| Q3 2018 | $1,028,000 | +16.3% | 28,271 | +20.8% | 0.00% | 0.0% |
| Q2 2018 | $884,000 | +1424.1% | 23,412 | +122.3% | 0.00% | – |
| Q4 2016 | $58,000 | -43.1% | 10,530 | -20.5% | 0.00% | – |
| Q3 2016 | $102,000 | -22.1% | 13,253 | -25.3% | 0.00% | – |
| Q2 2016 | $131,000 | -74.1% | 17,731 | -41.9% | 0.00% | -100.0% |
| Q4 2015 | $505,000 | +130.6% | 30,494 | +276.7% | 0.00% | – |
| Q2 2015 | $219,000 | -1.4% | 8,096 | -11.6% | 0.00% | – |
| Q1 2015 | $222,000 | – | 9,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |